Back to DE D. E. Shaw & Co., Inc.
CLDX
Showing 0 of 2 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in Celldex Therapeutics, Inc.
As of its Q4 2018 13F, D. E. Shaw held 73,331 shares of CLDX (Celldex Therapeutics), worth $15,000.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.